NOVONESIS A/S NAM. B DK 2
NOVONESIS A/S NAM. B DK 2/ DK0060336014 /
NZM2
8/5/2024 12:30:42 PM
|
Chg.
-1.20
|
Volume |
Bid1:09:07 PM |
Ask1:09:07 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
55.66EUR
|
-2.11%
|
0 Turnover: 0.00 |
55.68Bid Size: 650 |
55.90Ask Size: 650 |
15.47 bill.EUR |
- |
- |
Business description
Novozymes is the world leader in biological solutions. As the world’s largest provider of enzyme and microbial technologies, the company´s bioinnovation enables higher agricultural yields, low-temperature washing, energy-efficient production, renewable fuel and many other benefits.
Management board & Supervisory board
CEO |
Ester Baiget |
Management board |
Rainer Lehmann, Amy Byrick, Anders Lund, Claus Crone Fuglsang, Graziela Chaluppe dos Santos Malucelli, Morten Enggaard Rasmussen, Tina Sejersgård Fanø |
Supervisory board |
Cees de Jong, Andreas Hentze Knudsen, Anne Breum, Cees de Jong, Heine Dalsgaard, Jens Øbro, Kasim Kutay, Kim Stratton, Mathias Uhlén, Preben Nielsen, Sharon James |
Company data
Name: |
Novozymes A.S |
Address: |
Krogshoejvej 36,DK-2880 Bagsvaerd |
Phone: |
+45-44-460000 |
Fax: |
- |
E-mail: |
-
|
Internet: |
www.novozymes.com/ |
Industry: |
Biotechnology |
Sector: |
Biotechnology |
Sub sector: |
Biotechnology |
End of financial year: |
12/31 |
Free Float: |
74.50% |
IPO date: |
11/20/2000 |
Company calendar
CW 35 | 8/28/2024
Interim Report 2nd Quarter/6 Months
|
CW 45 | 11/7/2024
Interim Report 3rd Quarter/9 Months
|
CW 9 | 2/26/2025
4th Quarter/Annual Report
|
CW 14 | 4/3/2025
General Shareholder Meeting
|